News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chiromics and Bristol-Myers Squibb Company (BMY) Form Drug Discovery Strategic Alliance


11/9/2012 11:23:01 AM

PRINCETON, N.J.--(BUSINESS WIRE)--Chiromics LLC today announced a strategic research alliance with Bristol-Myers Squibb Company (NYSE:BMY) which includes grants of non-exclusive license for use of Chiromics’ chemical compound library, exclusive license to a proprietary chemical compound collection, and a screening collaboration to discover and optimize novel classes of small molecules against multiple therapeutic targets.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES